// App-Quantinova.ai

3341 : Autologous Stem Cell Transplantation Improves Survival For High Risk Cardiac Amyloidosis

Researchers

Presenter

  • Piyanuch Kongtim

Principal Investigators

  • Muzaffar H. Qazilbash

  • Jatin J. Shah

  • Robert Z. Orlowski

  • Amir Hamdi

  • Nina Shah

  • Qaiser Bashir

  • Michael Wang

  • Richard E. Champlin

  • Simrit Parmar

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • AL Amyloidosis

  • Cardiac amyloidosis

Biomarkers

  • Troponin I

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Melphalan

  • PR-63

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved